Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 … - CNNMoney.com
Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 …CNNMoney.com - 8 hours ago"The initiation of our second pivotal Phase 3 trial for EOquin in non-invasive bladder cancer patients demonstrates the significant progress we are making …Threshold Pharmaceuticals Announces Two Presentations on … CNNMoney.comOzarelix Phase 2 Data Presented at 29th Congress of the Societe … CNNMoney.comall 14 news articles
Read full story